{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Houttuynia cordata thunb.", "homology of medicine and food", "immunity", "inflammatory bowel disease", "intestinal microenvironment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38077358", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "22"}], "Language": ["eng"], "ELocationID": ["1306375", "10.3389/fimmu.2023.1306375"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Houttuynia cordata thunb. alleviates inflammatory bowel disease by modulating intestinal microenvironment: a research review.", "Pagination": {"StartPage": "1306375", "MedlinePgn": "1306375"}, "Abstract": {"AbstractText": ["Inflammatory bowel disease (IBD) is a complex group of chronic intestinal diseases, the cause of which has not yet been clarified, but it is widely believed that the disorder of the intestinal microenvironment and its related functional changes are key factors in the development of the disease. Houttuynia cordata thunb. is a traditional plant with abundant resources and long history of utilization in China, which has attracted widespread attention in recent years due to its potential in the treatment of IBD. However, its development and utilization are limited owing to the aristolochic acid alkaloids contained in it. Therefore, based on the relationship between the intestinal microenvironment and IBD, this article summarizes the potential mechanisms by which the main active ingredients of Houttuynia cordata thunb., such as volatile oils, polysaccharides, and flavonoids, and related traditional Chinese medicine preparations, such as Xiezhuo Jiedu Formula, alleviate IBD by regulating the intestinal microenvironment. At the same time, combined with current reports, the medicinal and edible safety of Houttuynia cordata thunb. is explained for providing ideas for further research and development of Houttuynia chordate thunb. in IBD disease, more treatment options for IBD patients, and more insights into the therapeutic potential of plants with homology of medicine and food in intestinal diseases, and even more diseases."], "CopyrightInformation": "Copyright \u00a9 2023 Wang, Li, Chen, Liu, Zhou, Li, Wu and Yuan."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Clinical School of Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Wang", "ForeName": "Si", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Li", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Chen", "ForeName": "Yuhan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Liu", "ForeName": "Qian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Zhou", "ForeName": "Shengyu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Clinical School of Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Li", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}, {"Identifier": [], "Affiliation": "Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Wu", "ForeName": "Yueying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}, {"Identifier": [], "Affiliation": "Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China."}], "LastName": "Yuan", "ForeName": "Jiali", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't", "Comment"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "CommentsCorrectionsList": [{"RefSource": "Inflamm Bowel Dis. 2023 Sep 1;29(9):1362-1369. doi: 10.1093/ibd/izad058", "PMID": "37655859"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Houttuynia"}, {"QualifierName": [], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Alkaloids"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammatory Bowel Diseases"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhou F, Zhang GD, Tan Y, Hu SA, Tang Q, Pei G. NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease. Therap Adv Gastroenterol (2023) 16:17562848231176889. doi:\u00a010.1177/17562848231176889", "ArticleIdList": ["10.1177/17562848231176889", "PMC10493068", "37701792"]}, {"Citation": "Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet (2017) 390(10114):2769\u201378. doi:\u00a010.1016/S0140-6736(17)32448-0", "ArticleIdList": ["10.1016/S0140-6736(17)32448-0", "29050646"]}, {"Citation": "Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res (2020) 9:1\u201313. doi:\u00a010.12688/f1000research.20805.1", "ArticleIdList": ["10.12688/f1000research.20805.1", "PMC7194476", "32399194"]}, {"Citation": "Wang Y, Li Q, Zhang J, Liu P, Zheng H, Chen L, et al. . Ring1a protects against colitis through regulating mucosal immune system and colonic microbial ecology. Gut Microbes (2023) 15(2):2251646. doi:\u00a010.1080/19490976.2023.2251646", "ArticleIdList": ["10.1080/19490976.2023.2251646", "PMC10478745", "37655448"]}, {"Citation": "Yan PG, Li JN. Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease. Chin Med J (Engl) (2020) 133(7):834\u201341. doi:\u00a010.1097/CM9.0000000000000718", "ArticleIdList": ["10.1097/CM9.0000000000000718", "PMC7147659", "32106123"]}, {"Citation": "Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet (2023) 402(10401):571\u201384. doi:\u00a010.1016/S0140-6736(23)00966-2", "ArticleIdList": ["10.1016/S0140-6736(23)00966-2", "37573077"]}, {"Citation": "Zhong G, He C, Wang S, Lin C, Li M. Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity. Front Immunol (2023) 14:1241262. doi:\u00a010.3389/fimmu.2023.1241262", "ArticleIdList": ["10.3389/fimmu.2023.1241262", "PMC10500599", "37720208"]}, {"Citation": "Shingnaisui K, Dey T, Manna P, Kalita J. Therapeutic potentials of Houttuynia cordata Thunb. against inflammation and oxidative stress: A review. J Ethnopharmacol (2018) 220:35\u201343. doi:\u00a010.1016/j.jep.2018.03.038", "ArticleIdList": ["10.1016/j.jep.2018.03.038", "PMC7127360", "29605674"]}, {"Citation": "Xu Z, Wang C, Bao W, Weng H, Chen D, Lu Y. In vitro nephrotoxicity and quantitative UPLC-MS analysis of three aristololactams in Houttuynia cordata. J Pharm BioMed Anal (2023) 227:115289. doi:\u00a010.1016/j.jpba.2023.115289", "ArticleIdList": ["10.1016/j.jpba.2023.115289", "36812795"]}, {"Citation": "Ho TY, Lo HY, Lu GL, Liao PY, Hsiang CY. Analysis of target organs of Houttuynia cordata: A study on the anti-inflammatory effect of upper respiratory system. J Ethnopharmacol (2023) 315:116687. doi:\u00a010.1016/j.jep.2023.116687", "ArticleIdList": ["10.1016/j.jep.2023.116687", "37244408"]}, {"Citation": "Chen Y, Zhou D, Feng Y, Li B, Cui Y, Chen G, et al. . Association of sirtuins (SIRT1-7) with lung and intestinal diseases. Mol Cell Biochem (2022) 477(11):2539\u201352. doi:\u00a010.1007/s11010-022-04462-9", "ArticleIdList": ["10.1007/s11010-022-04462-9", "35594000"]}, {"Citation": "Jiang XL, Cui HF. Different therapy for different types of ulcerative colitis in China. World J Gastroenterol (2004) 10(10):1513\u201320. doi:\u00a010.3748/wjg.v10.i10.1513", "ArticleIdList": ["10.3748/wjg.v10.i10.1513", "PMC4656295", "15133864"]}, {"Citation": "Zhang H, Sun L. When human cells meet bacteria: precision medicine for cancers using the microbiota. Am J Cancer Res (2018) 8(7):1157\u201375. doi: 10.1158/1538-7445.AM2018-1157", "ArticleIdList": ["10.1158/1538-7445.AM2018-1157", "PMC6079160", "30094091"]}, {"Citation": "Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory bowel diseases and gut microbiota. Int J Mol Sci (2023) 24(4):746998. doi:\u00a010.3390/ijms24043817", "ArticleIdList": ["10.3390/ijms24043817", "PMC9958622", "36835245"]}, {"Citation": "Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest (2014) 124(10):4190\u20136. doi:\u00a010.1172/JCI72330", "ArticleIdList": ["10.1172/JCI72330", "PMC4191005", "25083986"]}, {"Citation": "Su M, Tang T, Tang W, Long Y, Wang L, Liu M. Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. Front Immunol (2023) 14:1243834. doi:\u00a010.3389/fimmu.2023.1243834", "ArticleIdList": ["10.3389/fimmu.2023.1243834", "PMC10450032", "37638043"]}, {"Citation": "Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? World J Gastroenterol (2021) 27(23):3317\u201326. doi:\u00a010.3748/wjg.v27.i23.3317", "ArticleIdList": ["10.3748/wjg.v27.i23.3317", "PMC8218353", "34163114"]}, {"Citation": "Sommer F, Anderson JM, Bharti R, Raes J, Rosenstiel P. The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol (2017) 15(10):630\u20138. doi:\u00a010.1038/nrmicro.2017.58", "ArticleIdList": ["10.1038/nrmicro.2017.58", "28626231"]}, {"Citation": "Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol (2018) 11(1):1\u201310. doi:\u00a010.1007/s12328-017-0813-5", "ArticleIdList": ["10.1007/s12328-017-0813-5", "29285689"]}, {"Citation": "Pickard JM, Zeng MY, Caruso R, Nunez G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev (2017) 279(1):70\u201389. doi:\u00a010.1111/imr.12567", "ArticleIdList": ["10.1111/imr.12567", "PMC5657496", "28856738"]}, {"Citation": "Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol (2019) 16(10):605\u201316. doi:\u00a010.1038/s41575-019-0173-3", "ArticleIdList": ["10.1038/s41575-019-0173-3", "31296969"]}, {"Citation": "Glassner KL, Abraham BP, Quigley E. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol (2020) 145(1):16\u201327. doi:\u00a010.1016/j.jaci.2019.11.003", "ArticleIdList": ["10.1016/j.jaci.2019.11.003", "31910984"]}, {"Citation": "Herrera-deGuise C, Varela E, Sarrabayrouse G, Pozuelo DRM, Alonso VR, Sainz NB, et al. . Gut microbiota composition in long-remission ulcerative colitis is close to a healthy gut microbiota. Inflammation Bowel Dis (2023) 29(9):1362\u20139. doi:\u00a010.1093/ibd/izad058", "ArticleIdList": ["10.1093/ibd/izad058", "37655859"]}, {"Citation": "Shang S, Zhu J, Liu X, Wang W, Dai T, Wang L, et al. . The impacts of fecal microbiota transplantation from same sex on the symptoms of ulcerative colitis patients. Pol J Microbiol (2023) 72(3):247\u201368. doi:\u00a010.33073/pjm-2023-025", "ArticleIdList": ["10.33073/pjm-2023-025", "PMC10508974", "37725892"]}, {"Citation": "Javed NH, Alsahly MB, Khubchandani J. Oral feeding of probiotic bifidobacterium infantis: colonic morphological changes in rat model of TNBS-induced colitis. Scientifica (Cairo) (2016) 2016:9572596. doi:\u00a010.1155/2016/9572596", "ArticleIdList": ["10.1155/2016/9572596", "PMC4834163", "27127686"]}, {"Citation": "Zhang B, Liu Y, Lan X, Xu X, Zhang X, Li X, et al. . Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice. J Transl Med (2018) 16(1):71. doi:\u00a010.1186/s12967-018-1441-7", "ArticleIdList": ["10.1186/s12967-018-1441-7", "PMC5859778", "29554971"]}, {"Citation": "Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World J Gastroenterol (2023) 29(14):2078\u2013100. doi:\u00a010.3748/wjg.v29.i14.2078", "ArticleIdList": ["10.3748/wjg.v29.i14.2078", "PMC10130969", "37122604"]}, {"Citation": "Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol (2020) 17(4):223\u201337. doi:\u00a010.1038/s41575-019-0258-z", "ArticleIdList": ["10.1038/s41575-019-0258-z", "32076145"]}, {"Citation": "Suh JH, Degagne E, Gleghorn EE, Setty M, Rodriguez A, Park KT, et al. . Sphingosine-1-phosphate signaling and metabolism gene signature in pediatric inflammatory bowel disease: A matched-case control pilot study. Inflammation Bowel Dis (2018) 24(6):1321\u201334. doi:\u00a010.1093/ibd/izy007", "ArticleIdList": ["10.1093/ibd/izy007", "PMC5986285", "29788359"]}, {"Citation": "Wlodarska M, Luo C, Kolde R, D'Hennezel E, Annand JW, Heim CE, et al. . Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation. Cell Host Microbe (2017) 22(1):25\u201337.e6. doi:\u00a010.1016/j.chom.2017.06.007", "ArticleIdList": ["10.1016/j.chom.2017.06.007", "PMC5672633", "28704649"]}, {"Citation": "Yan Y, Lei Y, Qu Y, Fan Z, Zhang T, Xu Y, et al. . Bacteroides uniformis-induced perturbations in colonic microbiota and bile acid levels inhibit TH17 differentiation and ameliorate colitis developments. NPJ Biofilms Microbiomes (2023) 9(1):56. doi:\u00a010.1038/s41522-023-00420-5", "ArticleIdList": ["10.1038/s41522-023-00420-5", "PMC10425470", "37580334"]}, {"Citation": "Su X, Gao Y, Yang R. Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity. Front Immunol (2023) 14:1127743. doi:\u00a010.3389/fimmu.2023.1127743", "ArticleIdList": ["10.3389/fimmu.2023.1127743", "PMC10225537", "37256134"]}, {"Citation": "Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab (2016) 24(1):41\u201350. doi:\u00a010.1016/j.cmet.2016.05.005", "ArticleIdList": ["10.1016/j.cmet.2016.05.005", "27320064"]}, {"Citation": "Long XQ, Liu MZ, Liu ZH, Xia LZ, Lu SP, Xu XP, et al. . Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease. World J Gastroenterol (2023) 29(27):4252\u201370. doi:\u00a010.3748/wjg.v29.i27.4252", "ArticleIdList": ["10.3748/wjg.v29.i27.4252", "PMC10401658", "37545642"]}, {"Citation": "Di Ciaula A, Bonfrate L, Khalil M, Portincasa P. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Intern Emerg Med (2023) 18(8):2181\u201397. doi:\u00a010.1007/s11739-023-03343-3", "ArticleIdList": ["10.1007/s11739-023-03343-3", "PMC10635993", "37515676"]}, {"Citation": "Han B, Lv X, Liu G, Li S, Fan J, Chen L, et al. . Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-alpha4beta7-integrin therapy in humanized mice with colitis. Gut Microbes (2023) 15(1):2232143. doi:\u00a010.1080/19490976.2023.2232143", "ArticleIdList": ["10.1080/19490976.2023.2232143", "PMC10337508", "37431863"]}, {"Citation": "Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol (2019) 12(4):851\u201361. doi:\u00a010.1038/s41385-019-0162-4", "ArticleIdList": ["10.1038/s41385-019-0162-4", "30952999"]}, {"Citation": "Kubota H, Ishizawa M, Kodama M, Nagase Y, Kato S, Makishima M, et al. . Vitamin D receptor mediates attenuating effect of lithocholic acid on dextran sulfate sodium induced colitis in mice. Int J Mol Sci (2023) 24(4):3517. doi:\u00a010.3390/ijms24043517", "ArticleIdList": ["10.3390/ijms24043517", "PMC9965401", "36834927"]}, {"Citation": "Parada VD, de la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, et al. . Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol (2019) 10:277. doi:\u00a010.3389/fimmu.2019.00277", "ArticleIdList": ["10.3389/fimmu.2019.00277", "PMC6421268", "30915065"]}, {"Citation": "Recharla N, Geesala R, Shi XZ. Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: A literature review. Nutrients (2023) 15(10):2275. doi:\u00a010.3390/nu15102275", "ArticleIdList": ["10.3390/nu15102275", "PMC10221771", "37242159"]}, {"Citation": "Vereecke L, Beyaert R, van Loo G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med (2011) 17(10):584\u201393. doi:\u00a010.1016/j.molmed.2011.05.011", "ArticleIdList": ["10.1016/j.molmed.2011.05.011", "21741311"]}, {"Citation": "Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol (2008) 181(6):3733\u20139. doi:\u00a010.4049/jimmunol.181.6.3733", "ArticleIdList": ["10.4049/jimmunol.181.6.3733", "18768823"]}, {"Citation": "Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 25(12):677\u201386. doi:\u00a010.1016/j.it.2004.09.015", "ArticleIdList": ["10.1016/j.it.2004.09.015", "15530839"]}, {"Citation": "Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y, et al. . Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep (2016) 6:24838. doi:\u00a010.1038/srep24838", "ArticleIdList": ["10.1038/srep24838", "PMC4837405", "27094081"]}, {"Citation": "Liu T, Sun Z, Yang Z, Qiao X. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides. BioMed Pharmacother (2023) 162:114586. doi:\u00a010.1016/j.biopha.2023.114586", "ArticleIdList": ["10.1016/j.biopha.2023.114586", "36989711"]}, {"Citation": "Wang S, van Schooten FJ, Jin H, Jonkers D, Godschalk R. The involvement of intestinal tryptophan metabolism in inflammatory bowel disease identified by a meta-analysis of the transcriptome and a systematic review of the metabolome. Nutrients (2023) 15(13):2886. doi:\u00a010.3390/nu15132886", "ArticleIdList": ["10.3390/nu15132886", "PMC10346271", "37447212"]}, {"Citation": "Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun (2018) 9(1):3294. doi:\u00a010.1038/s41467-018-05470-4", "ArticleIdList": ["10.1038/s41467-018-05470-4", "PMC6098093", "30120222"]}, {"Citation": "Yang C, Zhao Y, Im S, Nakatsu C, Jones-Hall Y, Jiang Q. Vitamin E delta-tocotrienol and metabolite 13\u2019-carboxychromanol inhibit colitis-associated colon tumorigenesis and modulate gut microbiota in mice. J Nutr Biochem (2021) 89:108567. doi:\u00a010.1016/j.jnutbio.2020.108567", "ArticleIdList": ["10.1016/j.jnutbio.2020.108567", "33347911"]}, {"Citation": "Bischoff SC, Kaden-Volynets V, Filipe RL, Guseva D, Seethaler B. Regulation of the gut barrier by carbohydrates from diet - Underlying mechanisms and possible clinical implications. Int J Med Microbiol (2021) 311(4):151499. doi:\u00a010.1016/j.ijmm.2021.151499", "ArticleIdList": ["10.1016/j.ijmm.2021.151499", "33864957"]}, {"Citation": "Pierre JF, Hinterleitner R, Bouziat R, Hubert NA, Leone V, Miyoshi J, et al. . Dietary antioxidant micronutrients alter mucosal inflammatory risk in a murine model of genetic and microbial susceptibility. J Nutr Biochem (2018) 54:95\u2013104. doi:\u00a010.1016/j.jnutbio.2017.12.002", "ArticleIdList": ["10.1016/j.jnutbio.2017.12.002", "PMC5866768", "29331497"]}, {"Citation": "Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da CG, et al. . CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med (2016) 22(6):598\u2013605. doi:\u00a010.1038/nm.4102", "ArticleIdList": ["10.1038/nm.4102", "PMC5087285", "27158904"]}, {"Citation": "Wojciech L, Png CW, Koh EY, Kioh D, Deng L, Wang Z, et al. . A tryptophan metabolite made by a gut microbiome eukaryote induces pro-inflammatory T cells. EMBO J (2023) 42(21):e112963. doi:\u00a010.15252/embj.2022112963", "ArticleIdList": ["10.15252/embj.2022112963", "PMC10620759", "37743772"]}, {"Citation": "Hsu CN, Tain YL. Developmental programming and reprogramming of hypertension and kidney disease: impact of tryptophan metabolism. Int J Mol Sci (2020) 21(22):8705. doi:\u00a010.3390/ijms21228705", "ArticleIdList": ["10.3390/ijms21228705", "PMC7698939", "33218054"]}, {"Citation": "Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, et al. . Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity (2014) 41(2):296\u2013310. doi:\u00a010.1016/j.immuni.2014.06.014", "ArticleIdList": ["10.1016/j.immuni.2014.06.014", "PMC4142105", "25065623"]}, {"Citation": "Ding X, Bin P, Wu W, Chang Y, Zhu G. Tryptophan metabolism, regulatory T cells, and inflammatory bowel disease: A mini review. Mediators Inflammation (2020) 2020:9706140. doi:\u00a010.1155/2020/9706140", "ArticleIdList": ["10.1155/2020/9706140", "PMC7306093", "32617076"]}, {"Citation": "Nikolaus S, Schulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, et al. . Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology (2017) 153(6):1504\u20131516.e2. doi:\u00a010.1053/j.gastro.2017.08.028", "ArticleIdList": ["10.1053/j.gastro.2017.08.028", "28827067"]}, {"Citation": "Nanda GC, Padhi MM, Pathak NN, Choppra KK. Screening of Madhumehaghna (anti diabetic) plants in Vrihattrayee. Bull Indian Inst Hist Med Hyderabad (2000) 30(1):15\u201326.", "ArticleIdList": ["12578004"]}, {"Citation": "Kumar M, Prasad SK, Hemalatha S. A current update on the phytopharmacological aspects of Houttuynia cordata Thunb. Pharmacogn Rev (2014) 8(15):22\u201335. doi:\u00a010.4103/0973-7847.125525", "ArticleIdList": ["10.4103/0973-7847.125525", "PMC3931198", "24600193"]}, {"Citation": "Rafiq S, Hao H, Ijaz M, Raza A. Pharmacological Effects of Houttuynia cordata Thunb (H. cordata): A Comprehensive Review. Pharm (Basel) (2022) 15(9):1079. doi:\u00a010.3390/ph15091079", "ArticleIdList": ["10.3390/ph15091079", "PMC9501394", "36145299"]}, {"Citation": "Ma Q, Wei R, Wang Z, Liu W, Sang Z, Li Y, et al. . Bioactive alkaloids from the aerial parts of Houttuynia cordata. J Ethnopharmacol (2017) 195:166\u201372. doi:\u00a010.1016/j.jep.2016.11.013", "ArticleIdList": ["10.1016/j.jep.2016.11.013", "27840258"]}, {"Citation": "Wang Y, Zhan Y, Ji C, Shi C, Han J. Houttuynia cordata Thunb repairs steroid-induced avascular necrosis of the femoral head through regulating NF-kappaB signaling pathway. Toxicon (2023) 233:107270. doi:\u00a010.1016/j.toxicon.2023.107270", "ArticleIdList": ["10.1016/j.toxicon.2023.107270", "37652100"]}, {"Citation": "Xu X, Liu S, Zhao Y, Wang M, Hu L, Li W, et al. . Combination of Houttuynia cordata polysaccharide and Lactiplantibacillus plantarum P101 alleviates acute liver injury by regulating gut microbiota in mice. J Sci Food Agric (2022) 102(15):6848\u201357. doi:\u00a010.1002/jsfa.12046", "ArticleIdList": ["10.1002/jsfa.12046", "35639719"]}, {"Citation": "Li M, Wang C, Xu WT, Zhong X. Sodium houttuyfonate plays a protective role in the asthmatic airway by alleviating the NLRP3-related pyroptosis and Th1/Th2 immune imbalance. Mol Immunol (2023) 160:103\u201311. doi:\u00a010.1016/j.molimm.2023.06.013", "ArticleIdList": ["10.1016/j.molimm.2023.06.013", "37413910"]}, {"Citation": "Tang J, Zhou L, Yuan G, Liu Y, Shi X, Lu Y, et al. . Therapeutic effects on H1N1-induced pneumonia in mice and intestinal bacteria biotransformation of four main flavonoids from Houttuynia cordata Thunb. J Pharm BioMed Anal (2023) 233:115469. doi:\u00a010.1016/j.jpba.2023.115469", "ArticleIdList": ["10.1016/j.jpba.2023.115469", "37244222"]}, {"Citation": "Ju IG, Lee S, Choi JG, Kim N, Huh E, Lee JK, et al. . Aerial part of Houttuynia cordata reverses memory impairment by regulating amyloid beta accumulation and neuroinflammation in Alzheimer\u2019s disease model. Phytother Res (2023) 37(7):2854\u201363. doi:\u00a010.1002/ptr.7781", "ArticleIdList": ["10.1002/ptr.7781", "36814130"]}, {"Citation": "Tan R, You Q, Cui J, Wang M, Song N, An K, et al. . Sodium houttuyfonate against cardiac fibrosis attenuates isoproterenol-induced heart failure by binding to MMP2 and p38. Phytomedicine (2023) 109:154590. doi:\u00a010.1016/j.phymed.2022.154590", "ArticleIdList": ["10.1016/j.phymed.2022.154590", "36610170"]}, {"Citation": "Navarro V. The world health situation. Int J Health Serv (2004) 34(1):1\u201310. doi:\u00a010.2190/4HMT-KDKH-18E7-2XBE", "ArticleIdList": ["10.2190/4HMT-KDKH-18E7-2XBE", "15088668"]}, {"Citation": "Cheng T, Xu C, Wu D, Yan G, Wang C, Wang T, et al. . Sodium houttuyfonate derived from Houttuynia cordata Thunb improves intestinal malfunction via maintaining gut microflora stability in Candida albicans overgrowth aggravated ulcerative colitis. Food Funct (2023) 14(2):1072\u201386. doi:\u00a010.1039/d2fo02369e", "ArticleIdList": ["10.1039/d2fo02369e", "36594429"]}, {"Citation": "Zhang L, Lv H, Li Y, Dong N, Bi C, Shan A, et al. . Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-kappaB pathway in mice. Int Immunopharmacol (2020) 89(Pt A):107058. doi:\u00a010.1016/j.intimp.2020.107058", "ArticleIdList": ["10.1016/j.intimp.2020.107058", "33045570"]}, {"Citation": "Cen L, Yi T, Hao Y, Shi C, Shi X, Lu Y, et al. . Houttuynia cordata polysaccharides alleviate ulcerative colitis by restoring intestinal homeostasis. Chin J Nat Med (2022) 20(12):914\u201324. doi:\u00a010.1016/S1875-5364(22)60220-6", "ArticleIdList": ["10.1016/S1875-5364(22)60220-6", "36549805"]}, {"Citation": "He X, Hu M, Song C, Ni M, Liu L, Chen C, et al. . Sodium new houttuyfonate effectively improves phagocytosis and inhibitsthe excessive release of inflammatory factors by repressingTLR4/NF-\u041ab pathway in macrophages. Curr Pharm Biotechnol (2023) 24(15):1964\u201371. doi:\u00a010.2174/1389201024666230418163100", "ArticleIdList": ["10.2174/1389201024666230418163100", "37070797"]}, {"Citation": "Ping W, Jinqian L, Jing D, Shuo W, Zongqiang F, Zhen L, et al. . lmproving effect of houttuynia cordata polysaccharide on dextran sodium sulfate-induced ulcerative colitis. Sci Technol Food Industry (2021) 42(23):362\u20139. doi:\u00a010.13386/j.issn1002-0306.2021030063", "ArticleIdList": ["10.13386/j.issn1002-0306.2021030063"]}, {"Citation": "Letian Y, Chen Y, Xiaofei Y, Chang S, Gengxin Z, Fang C. Effect of tota flavonoids from Houttuvnia cordata Thunbon the treatment of colitis in mice. J Pharm Res (2022) 41(05):287\u201391. doi:\u00a010.13506/j.cnki.jpr.2022.05.002", "ArticleIdList": ["10.13506/j.cnki.jpr.2022.05.002"]}, {"Citation": "Lin R, Piao M, Song Y. Dietary quercetin increases colonic microbial diversity and attenuates colitis severity in citrobacter rodentium-infected mice. Front Microbiol (2019) 10:1092. doi:\u00a010.3389/fmicb.2019.01092", "ArticleIdList": ["10.3389/fmicb.2019.01092", "PMC6531918", "31156598"]}, {"Citation": "Xiao-meng L, Jian-ping L, Dian-gui L, Jie R, Xin K, Ming-min DU. Effects of Xiezhuo Jiedu Decoction on expressions of TLR2 mRNA and protein in colon tissue of ulcerative colitis rats. China J Tradit Chin Med Pharm (2017) 32(02):838\u201340."}, {"Citation": "Siyu L, Xiaomeng L, Jianping L, Kangxin . Preventing recurrence of Jianpi Xiezhuo Jiedu Recipe on inactive ulcerative colitisrats: based on intestinal flora. Hebei J Tradit Chin Med (2022) 44(09):1507\u201311. doi:\u00a010.3969/j.issn.1002-2619.2022.09.022", "ArticleIdList": ["10.3969/j.issn.1002-2619.2022.09.022"]}, {"Citation": "Zhoujin T, Hai W, Fulin L, Ying C, Guangxian C, Hualing Z, et al. . Effect of ultra-micro powder qiweibaishusan on the intestinal microbiota and enzyme activities in mice. Acta Ecol Sin (2012) 32(21):6856\u201363. doi: 10.5846/stxb201109271422", "ArticleIdList": ["10.5846/stxb201109271422"]}, {"Citation": "Li C, Zhou K, Xiao N, Peng M, Tan Z. The effect of qiweibaizhu powder crude polysaccharide on antibiotic-associated diarrhea mice is associated with restoring intestinal mucosal bacteria. Front Nutr (2022) 9:952647. doi:\u00a010.3389/fnut.2022.952647", "ArticleIdList": ["10.3389/fnut.2022.952647", "PMC9305308", "35873450"]}, {"Citation": "Yang L, Jiang J. Bioactive components and functional properties of Hottuynia cordata and its applications. Pharm Biol (2009) 12):1154\u201361. doi: 10.3109/13880200903019200", "ArticleIdList": ["10.3109/13880200903019200"]}, {"Citation": "Zhang S, Zhang M, Li W, Ma L, Liu X, Ding Q, et al. . Research progress of natural plant polysaccharides inhibiting inflammatory signaling pathways and regulating intestinal flora and metabolism to protect inflammatory bowel disease. Int J Biol Macromol (2023) 253(Pt 4):126799. doi:\u00a010.1016/j.ijbiomac.2023.126799", "ArticleIdList": ["10.1016/j.ijbiomac.2023.126799", "37703965"]}, {"Citation": "Laldinsangi C. The therapeutic potential of Houttuynia cordata: A current review. Heliyon (2022) 8(8):e10386. doi:\u00a010.1016/j.heliyon.2022.e10386", "ArticleIdList": ["10.1016/j.heliyon.2022.e10386", "PMC9433674", "36061012"]}, {"Citation": "Chou SC, Su CR, Ku YC, Wu TS. The constituents and their bioactivities of Houttuynia cordata. Chem Pharm Bull (Tokyo) (2009) 57(11):1227\u201330. doi:\u00a010.1248/cpb.57.1227", "ArticleIdList": ["10.1248/cpb.57.1227", "19881272"]}, {"Citation": "Michl J, Ingrouille MJ, Simmonds MS, Heinrich M. Naturally occurring aristolochic acid analogues and their toxicities. Nat Prod Rep (2014) 31(5):676\u201393. doi:\u00a010.1039/c3np70114j", "ArticleIdList": ["10.1039/c3np70114j", "24691743"]}, {"Citation": "Probstle A, Bauer R. Aristolactams and a 4,5-dioxoaporphine derivative from Houttuynia cordata. Planta Med (1992) 58(6):568\u20139. doi:\u00a010.1055/s-2006-961554", "ArticleIdList": ["10.1055/s-2006-961554", "1484899"]}, {"Citation": "Bauer R, Probstle A, Lotter H, Wagner-Redecker W, Matthiesen U. Cyclooxygenase inhibitory constituents from Houttuynia cordata. Phytomedicine (1996) 2(4):305\u20138. doi:\u00a010.1016/S0944-7113(96)80073-0", "ArticleIdList": ["10.1016/S0944-7113(96)80073-0", "23194766"]}, {"Citation": "Wei Q, Hua WF, Juan L, Jinyu L. Alkaloids from Houttuynia cordata and their antiplatelet aggregation activities. Chin J Nat Med (2011) 9(06):425\u20138. doi:\u00a010.3724/SP.J.1009.2011.00425", "ArticleIdList": ["10.3724/SP.J.1009.2011.00425"]}, {"Citation": "Mingxing Y, Jing C, Chunyang S, Wenqing W, Jianguo F. Study on the safety of Houttuynia from aristolochia lactam. Chin Tradit Herbal Drugs (2021) 52(19):6045\u201351. doi:\u00a010.7501/j.issn.0253-2670.2021.19.028", "ArticleIdList": ["10.7501/j.issn.0253-2670.2021.19.028"]}, {"Citation": "Chao D. A cross-sectional study on consumption habits of Houttuynia cordata and chronic kidney disease. Chin J Bioprocess Eng (2019) 17(02):189\u201394. doi:\u00a010.3969/j.issn.1672-3678.2019.02.012", "ArticleIdList": ["10.3969/j.issn.1672-3678.2019.02.012"]}, {"Citation": "Kang CK, Hah DS, Kim CH, Kim E, Kim JS. Evaluation of the genotoxicity of extracts of Houttuynia cordata Thunb. Am J Chin Med (2012) 40(5):1019\u201332. doi:\u00a010.1142/S0192415X12500759", "ArticleIdList": ["10.1142/S0192415X12500759", "22928832"]}, {"Citation": "Wu Z, Deng X, Hu Q, Xiao X, Jiang J, Ma X, et al. . Houttuynia cordata thunb: an ethnopharmacological review. Front Pharmacol (2021) 12:714694. doi:\u00a010.3389/fphar.2021.714694", "ArticleIdList": ["10.3389/fphar.2021.714694", "PMC8440972", "34539401"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "3"}, {"Year": "2023", "Month": "11", "Day": "6"}, {"Year": "2023", "Month": "12", "Day": "17", "Hour": "9", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "6", "Minute": "29"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["38077358", "PMC10702737", "10.3389/fimmu.2023.1306375"]}}], "PubmedBookArticle": []}